N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake
Peptide-based radiopharmaceuticals targeting neurotensin-receptor-1 (NTS<sub>1</sub>) are mainly stabilized using chemical modifications at the NT[8-13] sequence, thus increasing the stability and the uptake of the corresponding radionuclide-macrocycle-linker-bioconjugate. We postulate that the introduction of the linker at the <i>N</i>-term part induces additional cleavage sites that can be further stabilized to achieve a prolonged uptake. Double (JMV 7259 and JMV 7222) and triple-stabilized neurotensin analogues (JMV 7258 and JMV 7490) were synthesized, radiolabeled, and evaluated on HT-29 cells (NTS<sub>1</sub><sup>+</sup>). Nanomolar NTS<sub>1</sub>-affinity and high internalization rates were observed for all of the radiopharmaceuticals. Efflux was lower for radiolabeled JMV 7490. Consequently, [<sup>111</sup>In]In-JMV 7490 showed uptake of 5.86 ± 0.86 and 3.65 ± 0.29% ID/g of tissue in HT-29 xenografts at 1 and 4 h, respectively. We have successfully shown that high and persistent uptake of NTS<sub>1</sub>-positive tumor cells is achievable by stabilization of the N-term part. Efflux also appears to be a critical parameter for the successful targeting of NTS<sub>1</sub> using radiopharmaceuticals.
Authors
- Sacha Bodin (ORCID: https://orcid.org/0000-0001-7331-8536)
- Vincent Nail (ORCID: https://orcid.org/0000-0002-2958-7832)
- Elif Hindié (ORCID: https://orcid.org/0000-0003-2101-5626)
- Santo Previti
- Liaquat Ali (ORCID: https://orcid.org/0000-0001-9024-0291)
- Clément Morgat (ORCID: https://orcid.org/0000-0002-9432-9223)
- Florine Cavelier (ORCID: https://orcid.org/0000-0001-5308-6416)
- F. Lamare (ORCID: https://orcid.org/0000-0003-1289-7655)
- Delphine Vimont
- Simone U. Dalm (ORCID: https://orcid.org/0000-0002-6393-6901)
- Laure Balasse (ORCID: https://orcid.org/0000-0003-2057-7408)
- Tyrillshall S. T. Damiana
- Benjamin Guillet (ORCID: https://orcid.org/0000-0002-7578-6824)
- Emmanuelle Rémond (ORCID: https://orcid.org/0000-0002-3201-4365)
Institutions
- École Nationale Supérieure de Chimie de Montpellier (FR)
- Centre National de la Recherche Scientifique (FR)
- Université de Bordeaux (FR)
- Inserm (FR)
- École Pratique des Hautes Études (FR)
- Institut Universitaire de France (FR)
- Université de Montpellier (FR)
- Aix-Marseille Université (FR)
- Erasmus MC (NL)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Institut de Neurosciences Cognitives et Intégratives d’Aquitaine (FR)
- Imagerie Médicale et Radiothérapie Drôme Ardèche (FR)
- Institut des Biomolécules Max Mousseron (FR)
Publication Details
- Journal
- Journal of Medicinal Chemistry
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1021/acs.jmedchem.4c02844
- Primary Topic
- Neuropeptides and Animal Physiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Institut National Du Cancer